MAR 28, 2024 JLM 66°F 11:50 PM 05:50 PM EST
Blue and white breakthrough: A new Israeli drug will increase the life expectancy of lung patients

"Glacia" is produced from the plasma of healthy people, and reduces the need for lung transplantation in patients with a rare disease most often caused by smoking. Kamhada, which manufactures the drug in Kibbutz Negev, submitted it to the 2022 drug basket, after passing FDA and Ministry of Health approval, at an estimated cost of NIS 4 million.

The main cause of chronic obstructive pulmonary disease, also called COPD, is heavy smoking, but in a small proportion of patients (1% -3%), the disease is caused by a genetic deficiency in an essential protein called alpha 1, whose function is to protect the lungs from damage and infection. In these patients, an ongoing and irreversible process of lung tissue destruction takes place, from a relatively young age. Diagnosis of protein deficiency is determined through a series of tests, including a genetic test.

Did you find this article interesting?
Comments
James Greer 20:47 17.08.2021
I have copd and never smoked are they saying this. Will help give more time for someone? Thanks Israel PRAISE GOD AMEN LORD JESUS
Joanie Littlebear 20:29 17.08.2021
How can I get this medicine ???
To leave a comment, please log in

DISCOVER MORE

"Iron Swords" - War in Gaza Hamas The Iran Threat Biden Administration Hezbollah The Leftist-Islamist Alliance Israeli Technology Palestine = Hamas = ISIS Israeli_Nature 10/7 Hamas Massacres Biblical Archaeology Jihadi Infiltration into the West Heroes of Israel The Bible Muslim Persecution of Jews